Attached files

file filename
EX-10.1 - EX-10.1 - ASENSUS SURGICAL, INC.exhibit1.htm
 

 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   May 25, 2017

TransEnterix, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 0-19437 11-2962080
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
635 Davis Drive, Suite 300, Morrisville, North Carolina   27560
_________________________________
(Address of principal executive offices)
  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   919-765-8400

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 25, 2017, at the Annual Meeting of Stockholders for 2017 (the “Annual Meeting”), the stockholders of TransEnterix, Inc. (the “Company”) voted to approve, among other things, an Amendment to the Company’s Amended and Restated Incentive Compensation Plan, as amended (the “Plan”), to increase the number of shares reserved for issuance under the Plan by 7,000,000 shares. The vote for approval of the Amendment is set forth below under Item 5.07 and incorporated herein by reference.

The Amendment to the Plan is attached to this Current Report on Form 8-K and incorporated by reference into this Item.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 25, 2017, the Company held its Annual Meeting for 2017. At the Annual Meeting, the total number of shares represented in person or by proxy was 104,111,905 of the 123,629,689 shares of Common Stock outstanding and entitled to vote at the Annual Meeting as of the record date, April 10, 2017. The following matters were voted upon at the Annual Meeting:

1. Election of Directors. The following named persons were elected as Directors of the Company to serve until the next Annual Meeting of Stockholders in 2018 or until their successors are elected and qualified. The votes cast were as follows:

                 
Director Nominee   For   Vote Withheld
Paul A. LaViolette
    67,110,083       4,390,858  
Todd M. Pope
    70,114,050       1,386,891  
Andrea Biffi
    70,492,715       1,008,226  
Jane H. Hsiao
    67,818,404       3,682,537  
William N. Kelley
    67,378,975       4,121,966  
Aftab R. Kherani
    70,132,087       1,368,854  
David B. Milne
    70,482,228       1,018,713  
Richard C. Pfenniger, Jr.
    69,897,123       1,603,818  
William N. Starling
    70,085,690       1,415,251  

2. Say on Pay. The stockholders voted to approve, on an advisory basis, the compensation of the Company’s named executive officers for 2016, as described in the proxy statement in accordance with Regulation S-K, Item 402. The stockholder vote was as follows:

     
65,820,204 Votes
  FOR the resolution
5,483,988 Votes
  AGAINST the resolution
196,749 Votes
  ABSTAIN

3. Frequency of Say on Pay. The stockholders voted to approve the frequency of the submission of future Say on Pay proposals to the stockholders as once every year. The stockholder vote was as follows:

     
70,453,508 Votes
  ONE YEAR
165,068 Votes
  TWO YEARS
595,308 Votes
  THREE YEARS
287,057 Votes
  ABSTAIN

Following the Annual Meeting, and based upon the votes of the stockholders, approving annual Say on Pay proposals, the Board of Directors adopted and approved the recommendation of the stockholders and will submit annual Say on Pay proposals to the stockholders beginning with the 2018 annual meeting of stockholders.

4. Amendment and Restatement of the Incentive Compensation Plan. The stockholders voted to approve the amendment of the Plan to increase the number of shares reserved for issuance under the Plan by 7,000,000 shares. The stockholder vote was as follows:

     
62,810,724 Votes
  FOR the resolution
8,551,057 Votes
  AGAINST the resolution
139,160 Votes
  ABSTAIN

5. Ratification of Independent Public Accounting Firm for 2017. The stockholders voted to ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2017. The stockholder vote was as follows:

     
101,784,808 Votes
  FOR the resolution
1,588,610 Votes
  AGAINST the resolution
738,487 Votes
  ABSTAIN

Item 9.01 Financial Statements and Exhibits.

Exhibit No. Description

    10.1* Amendment to the TransEnterix Amended and Restated Incentive Compensation Plan, as amended.

      

*   A management contract, compensatory plan or arrangement required to be separately identified.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    TransEnterix, Inc.
          
May 25, 2017   By:   /s/ Joseph P. Slattery
       
        Name: Joseph P. Slattery
        Title: EVP and CFO


Exhibit Index


     
Exhibit No.   Description

 
10.1
  Amendment to the TransEnterix Amended and Restated Incentive Compensation Plan, as amended.